Arizona Tribune - Boulevard

NYSE - LSE

RBGPF	0%	65.61	$
CMSC	0.18%	21.99	$
CMSD	-0.14%	22.15	$
NGG	3.22%	82.85	$
RELX	1.72%	31.93	$
GSK	4.4%	53.66	$
AZN	5.79%	195.15	$
RIO	1.13%	94.42	$
RYCEF	1.27%	19.75	$
BTI	1.96%	61.77	$
VOD	1.06%	13.15	$
BCC	0.59%	75.93	$
BCE	1.87%	21.42	$
JRI	0.46%	13	$
BP	3.34%	37.4	$

Featured

Macabre night in La Guaira, Venezuela's earthquake epicenter

A macabre darkness, the glare of spotlights, the droning of generators and jackhammers, and often the stench of decomposing corpses: eight days after the double earthquake in Venezuela, nighttime in La Guaira, once a festive seaside resort, has transformed into a grim scene of survival and despair.

Venezuela's diaspora searches for quake victims on social media

From Ecuador, Switzerland and Germany, Maria Pessina and her siblings scoured chat groups and social media for news of their mother, after twin earthquakes struck Venezuela eight days ago.

Last news

Ensysce Biosciences Announces 1-for-15 Reverse Stock Split

Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company developing innovative solutions for severe pain relief while reducing the potential for opioid abuse and overdose, today announced that on Friday, December 6, 2024, effective at 12:01 a.m. Eastern Time, it will implement a 1-for-15 reverse split of its common stock. The Company's common stock will begin trading on a split-adjusted basis when the market opens on December 6, 2024, under its current trading symbol "ENSC". The new CUSIP number of the Company's common stock following the reverse stock split will be 293602 504.

Lakeland Industries to Attend Upcoming Investor Conferences in December

Lakeland Industries, Inc. (NASDAQ:LAKE) (the "Company" or "Lakeland"), a leading global manufacturer of protective clothing and apparel for industry, healthcare and first responders on the federal, state and local levels, today announced that management will attend the Benchmark 13thAnnual Discovery One-on-One Conference and the 13th Annual ROTH Deer Valley Event in December 2024.

CannapharmaRX Updates on Alberta Facility Progress and International Export Strategy

CannaPharmaRX, Inc. (OTC PINK:CPMD), a future leader in cannabis cultivation, is steadily advancing its position in high-efficiency cannabis production. The Company is excited to share its latest updates with shareholders and prospective investors, highlighting its substantial progress, current operations, and future growth plans.

The International Surface Event Highlights New Offerings and Product Discovery Ahead of January Event

The International Surface Event (tise), the largest flooring, stone and tile show in North America, returns to the Mandalay Bay Convention Center, January 28-30 (Education January 27-30), 2025, for three full days of exhibits and education from the industry's most innovative sources. With thousands of products on display and dynamic show-floor demonstrations of best practice, tise is an indispensable event for the surface, stone and tile industries where the widest range of products on the market are available under one roof, with more than 700 global brands showcasing materials, surfaces and flooring solutions. Bringing together over 21,000 industry professionals annually, attendees can discover the latest products, explore new trends and advance careers through education, certifications and networking opportunities.

Biofrontera Inc. to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference

, a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT), today announced it will be presenting at The Benchmark Company's 13th Annual Discovery One-on-One Investor Conference to be held Wednesday, December 11th, 2024 at the New York Athletic Club in New York City.

Enable Me Finds Improved Clinic Workflow, Patient Safety and Help with Staff Shortages are Among the Benefits of the Clinically Designed VELA Mammography Chair, Per an Informal Survey of Clinicians

The cost/benefit implications of applying the VELA Chair as an extension of the clinical team and a time saver point to a clear return on investment in the short term."For the patients who need it, it has absolutely streamlined and improved the workflow. I no longer need to have a second tech in the room to assist patients who are unstable on their feet or unable to stand."

Firstleaf Introduces New Holiday Wine Offerings Featuring Curated Bundles for Every Celebration

Firstleaf, the most personalized wine company in America, is ringing in the holiday season with a new selection of exclusive wine bundles designed to elevate festive gatherings and gift giving. Expertly curated by Firstleaf's wine team, these bundles feature wines from around the world and offer something special for every celebration.

Dermata Completes Enrollment in First Pivotal DMT310 Phase 3 STAR-1 Clinical Trial for Acne

- STAR-1 topline results expected in March 2025 -- Over 30 million acne patients seek treatment in the U.S. each year -- Phase 2b for DMT310 achieved statistically significant results for all primary endpoints -

BloomZ Partners with Badge Inc. to Revolutionize Fan Club Management

BloomZ Inc. (NASDAQ:BLMZ) ("BloomZ" or the "Company"), a leading Japanese anime production, audio production, and voice actor management company, announced a strategic business partnership with Badge Inc. ("Badge"), a Tokyo-based company specializing in online salon and fan club platforms.

LQR House Inc. Secures Liquor Control Board of Ontario (LCBO) Approval for SWOL Tequila in Ontario

First 1,000 Bottles Ordered by Of The Earth Distribution Corp., Marking Key Milestone in Canadian Market Expansion

M2i Global, Inc. to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference

, a company specializing in the development and execution of a complete global value supply chain for critical minerals, today announced it will be presenting at The Benchmark Company's 13th Annual Discovery One-on-One Investor Conference to be held Wednesday, December 11th, 2024 at the New York Athletic Club in New York City.

Rich Products to Celebrate #GivingTuesday with $80,000 in Grants to Food-Related Nonprofits

The initiative pays homage to Rich's impending 80th anniversary

Modular Medical Announces Conference Call to Provide Business Update

Modular Medical, Inc. (the "Company" or "Modular Medical") (Nasdaq:MODD), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult "almost-pumpers" with its user-friendly and affordable design, today announced it will hold a conference call and webcast on Thursday, December 5, 2024, at 10:00 a.m. Eastern Time to provide a business update.

CBD Life Sciences Inc. (CBDL) Announces New Delta-8 100MG Gummies Designed to Support Individuals Living With Alzheimer’s

Targeting a booming $6 billion U.S. edibles market with a projected $3 million in first-year revenue, CBDL delivers an innovative solution for Alzheimer's care.

NLS Pharmaceutics Announces Promising Preclinical Data for First-in-Class Non-Sulfonamide, Dual Orexin Receptor Agonists for the Potential Treatment of Narcolepsy and Neurological Disorders

NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) (NLS), a biopharmaceutical company, is pleased to share preclinical data demonstrating the potential of its dual orexin receptor agonist (DOXA) platform. AEX-41 and AEX-2, two first-in-class non-sulfonamide DOXAs, are designed to target both orexin-1 (OX1R) and orexin-2 (OX2R) receptors while concurrently inhibiting cathepsins. Cathepsins play significant roles in a variety of physiological processes and may offer a novel therapeutic approach for narcolepsy and other neurological disorders.

Telomir Pharmaceuticals Announces Reversal of Key Type 2 Diabetes Parameters in Groundbreaking Preclinical Study With Telomir-1

Building on preclinical success demonstrating age reversal, longevity, and increased healthspan, Telomir-1 appears to address insulin resistance at its root, achieving reversal to near pre-diabetic levels

InterContinental Hotels Group PLC Announces Transaction in Own Shares - December 03

The Company announces that on 02 December 2024 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2024 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 20 February 2024, as announced on 20 February 2024.

Musk $55.8 bn Tesla pay deal again rejected by US judge

A US judge on Monday upheld her decision to reject Elon Musk's massive $55.8 billion compensation package at Tesla, denying an attempt to restore the pay deal through a shareholder vote.

Vietnam property tycoon on death row faces appeal verdict

A Vietnamese property tycoon sentenced to death for a multi-billion-dollar fraud will learn Tuesday whether her life will be spared, as an appeal court reaches its verdict on one of the biggest corruption cases in history.

18 convicted in biggest UK drugs trial

A court has sentenced 18 members of an international crime group behind Britain's "biggest ever detected drugs conspiracy" to up to 32 years in jail after the country's longest-running criminal trial, police said Monday.

Suspect freed from custody over suicide capsule death in Switzerland

A man held since September over the death of a US woman inside a controversial suicide capsule in Switzerland was released from custody Monday, though he remains under suspicion.

Najib says bribery, power abuse charges 'politically motivated'

Malaysia's jailed ex-leader Najib Razak began his defence Monday against graft charges tied to more than $500 million in alleged bribes and several counts of money laundering, saying they were "politically motivated".

'Future of planet' at stake at ICJ hearings: Vanuatu

The future of the planet is at stake during hearings at the top United Nations court, a representative for Vanuatu said Monday, opening a historic case that aims to set a legal framework on how countries should tackle climate change.

30-strong Japan A-bomb delegation to collect Nobel prize

Japanese atomic bomb survivors' group Nihon Hidankyo said Monday a 30-strong delegation will collect its Nobel Peace Prize in Oslo after a crowd-funding campaign to pay their travel costs.

Four decades of horror after India's Bhopal gas disaster

Just after midnight as poisonous plumes of smoke wafted through the Indian city of Bhopal four decades ago, Gas Devi was born, gasping for every breath.

Biden pardons son Hunter in final weeks of presidency

US President Joe Biden on Sunday issued an official pardon for his son Hunter, who is facing sentencing for two criminal cases, despite assurances that he would not intervene in his legal troubles.

NHI Announces Appointment of Candice Todd to the Board of Directors

National Health Investors, Inc. (NYSE:NHI) announced today that Candice Todd will join the NHI Board of Directors effective January 1, 2025.

Allstar Health Brands, Inc. (ALST) Engages in Strategic Acquisition Negotiations with MergersCorp Investment Banking for Italian Soccer Team

All Star Health Brands is pleased to announce that it is entering the final stages of negotiations for the acquisition of a soccer team located in northern Italy, which has most recently competed in Serie D. This team boasts a dedicated stadium and an extensive youth development program, aligning with our strategic objectives to build international partnerships and foster youth engagement in both Canada and the United States.

Jaguar Health Participating in December 3-5 Pet Connect Conference with Goal of Identifying Partner to Develop and Commercialize NP300 Second-Generation Antisecretory Prescription Drug Candidate for Treatment of General Diarrhea in Dogs

Diarrhea is one of the most common reasons for veterinary visits for dogs and the second most common reason for visits to the veterinary emergency room, yet there are currently no FDA-approved drugs to treat general diarrhea in dogsCanalevia®-CA1, Jaguar's first-generation antisecretory drug for the treatment of chemotherapy-induced diarrhea in dogs, has received extension of conditional approval by FDA

Must-Visit Attractions in Sun Moon Lake, Taiwan: 2025 Sustainable Travel Recommendations

Sun Moon Lake is in central Taiwan's Yuchi Township of Nantou County. The vast Sun Moon Lake National Scenic Area includes this lake and the surrounding Shuili Township, Puli Town, Xinyi Township, and Jiji Town. This is a year-round tourist destination, with each season offering different experiences. In spring, enjoy hiking and cherry blossoms; in summer, enjoy water sports and fireflies. Bald cypress trees turn red in autumn and winter, and white plum blossoms appear.

Bausch Health Appoints New Chief Medical Officer and Head of R&D

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is pleased to announce the appointment of Jonathan Sadeh M.D., M.Sc as Executive Vice President, Chief Medical Officer and Head of R&D. This strategic addition to our leadership team underscores our commitment to innovation, excellence, and enriching lives.

Sunshine Biopharma Announces Breakthrough Research Results on the Company’s K1.1 mRNA Product as a Novel Therapeutic Agent for Human Hepatocellular Carcinoma

Sunshine Biopharma Inc. (NASDAQ:"SBFM") (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that it has completed mouse model studies providing proof-of-concept for the Company's K1.1 mRNA product as a novel therapeutic agent for human hepatocellular carcinoma.

Arizona Tribune - Boulevard (English)